MTOR and breast carcinoma: In our study, the increased level of this protein in G3 agreed with two complementary findings reported by two independent teams four years ago, revealing its suppression of breast cancer metastasis via the inhibition of two signaling pathways, PI3K/Akt/mTOR [82] and YAP/TAZ [83].